Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Geron Corporation (GERN)

« Back to company index

GERN Chatter Timeline

Stock Ticker for GERN

Most Active Tweeters for GERN

UserTweets
@OmarPridelands 35
@1000Shares 7
@Gambiste1 6
@MarcJacksonLA 3
@OilStocker 2

Recent Tweets for GERN

OmarPridelands @OmarPridelands
$gern check out imetelchat https://t.co/PFRgJ25q4D
April 19th 2021, 9:04pm
ChartMill @ChartMill
A Quick Ratio of 6.46 indicates that $GERN has no problem at all paying its short term obligations.… https://t.co/q4eIH7pR4o
April 19th 2021, 2:04am
FlashAlert_me @FlashAlert_me
$GERN [15s. delayed]: Issued Press Release on April 18, 08:00:00: Lifshitz Law Firm, P.C. Announces Investigations… https://t.co/3v7mN3sa6L
April 18th 2021, 12:04pm
OmarPridelands @OmarPridelands
$gern https://t.co/0m8MvcJZaB
April 17th 2021, 3:04am
OmarPridelands @OmarPridelands
RT @TMAN1138pm: $GERN #Bloodcancer #Imetelstat
April 16th 2021, 7:04pm
TMAN1138pm @TMAN1138pm
$GERN #Bloodcancer #Imetelstat https://t.co/Z6aA0Vx4Qk
April 16th 2021, 5:04pm
MarcJacksonLA @MarcJacksonLA
$GERN Phase 3 Study of Imtelstat Versus BAT Explores Survival Improvement in Myelofibrosis https://t.co/FRI1DA2WuL via @targetedonc
April 15th 2021, 8:04pm
OmarPridelands @OmarPridelands
RT @hadidy_sara: $GERN: Signals could not be any clearer on the 1-minute chart of GERN. Awaiting Buy Signal https://t.co/uLmwgJaeyx
April 15th 2021, 2:04pm
hadidy_sara @hadidy_sara
$GERN: Signals could not be any clearer on the 1-minute chart of GERN. Awaiting Buy Signal https://t.co/uLmwgJaeyx
April 15th 2021, 9:04am
OmarPridelands @OmarPridelands
RT @newsfilterio: Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis $GERN https://t.co/mV4…
April 14th 2021, 2:04pm
OmarPridelands @OmarPridelands
RT @1stOncology: #Geron Announces First Patient Dosed in #IMpactMF Phase 3 Clinical Trial in #Refractory #Myelofibrosis $GERN https://t.co/…
April 14th 2021, 2:04pm
1stOncology @1stOncology
#Geron Announces First Patient Dosed in #IMpactMF Phase 3 Clinical Trial in #Refractory #Myelofibrosis $GERN https://t.co/wEv1bVVfEh
April 14th 2021, 10:04am
newsfilterio @newsfilterio
Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis $GERN https://t.co/mV4QLJWFDC
April 14th 2021, 7:04am
newsfilterio @newsfilterio
Geron starts dosing in late-stage blood cancer study $GERN https://t.co/s8i4CHbCnU
April 14th 2021, 7:04am
OmarPridelands @OmarPridelands
@StockLizardKing $gern
April 13th 2021, 11:04pm
OmarPridelands @OmarPridelands
RT @SmallCapsDaily: $GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis Business Wire…
April 13th 2021, 6:04pm
OmarPridelands @OmarPridelands
RT @equity_newswire: $GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis https://t.co/…
April 13th 2021, 6:04pm
OmarPridelands @OmarPridelands
RT @HillScottW: $GERN Yuge drop in short interest and now this? nothing has changed. nice lotto https://t.co/p8wuxVWvbo
April 13th 2021, 6:04pm
HillScottW @HillScottW
$GERN Yuge drop in short interest and now this? nothing has changed. nice lotto https://t.co/p8wuxVWvbo
April 13th 2021, 6:04pm
equity_newswire @equity_newswire
$GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis https://t.co/C7E3XS3886
April 13th 2021, 5:04pm
SmallCapsDaily @SmallCapsDaily
$GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis Business W… https://t.co/bHVUBIPLp9
April 13th 2021, 3:04pm
OmarPridelands @OmarPridelands
RT @stock_titan: $GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis https://t.co/DQ49…
April 13th 2021, 2:04pm
OmarPridelands @OmarPridelands
RT @TeamofStockTra: $GERN - Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis
April 13th 2021, 2:04pm
OmarPridelands @OmarPridelands
RT @AkramMSiddique: $GERN - Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis
April 13th 2021, 2:04pm
OmarPridelands @OmarPridelands
RT @FlashAlert_me: $GERN [15s. delayed]: Issued Press Release on April 13, 07:30:00: Geron Announces First Patient Dosed in IMpactMF Phase…
April 13th 2021, 2:04pm
OmarPridelands @OmarPridelands
RT @sbwcws: Geron announces first patient dosed in IMpactMF trial $GERN
April 13th 2021, 2:04pm
OmarPridelands @OmarPridelands
RT @CHItraders: $GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis | Business Wire ht…
April 13th 2021, 2:04pm
OmarPridelands @OmarPridelands
RT @Beeken_health: $GERN - Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis https://t.co/…
April 13th 2021, 2:04pm
OmarPridelands @OmarPridelands
RT @MarketCurrents: $GERN - Geron starts dosing in late-stage blood cancer study https://t.co/LEA3m8hrcf
April 13th 2021, 2:04pm
OmarPridelands @OmarPridelands
RT @moneymessage_: $GERN - Geron starts dosing in late-stage blood cancer study https://t.co/nFMKyDfJJc
April 13th 2021, 2:04pm
MarcJacksonLA @MarcJacksonLA
$GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis | Business… https://t.co/vF92MjLyT9
April 13th 2021, 2:04pm
moneymessage_ @moneymessage_
$GERN - Geron starts dosing in late-stage blood cancer study https://t.co/nFMKyDfJJc
April 13th 2021, 1:04pm
OilStocker @OilStocker
$GERN @ $1.42 2021-04-13 @ 8:15 AM EST Geron Doses First Patient in Phase 3 Study of Potential Blood Cancer Drug I… https://t.co/ps18RNXskp
April 13th 2021, 12:04pm
OilStocker @OilStocker
$GERN @ $1.42 2021-04-13 @ 7:30 AM EST Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis
April 13th 2021, 12:04pm
MarketCurrents @MarketCurrents
$GERN - Geron starts dosing in late-stage blood cancer study https://t.co/LEA3m8hrcf
April 13th 2021, 11:04am
Beeken_health @Beeken_health
$GERN - Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis… https://t.co/ecNqqT9Hmc
April 13th 2021, 11:04am
CHItraders @CHItraders
$GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis | Business… https://t.co/frdz7xFh9y
April 13th 2021, 11:04am
sbwcws @sbwcws
Geron announces first patient dosed in IMpactMF trial $GERN
April 13th 2021, 11:04am
FlashAlert_me @FlashAlert_me
$GERN [15s. delayed]: Issued Press Release on April 13, 07:30:00: Geron Announces First Patient Dosed in IMpactMF P… https://t.co/iFqNIv5jJ7
April 13th 2021, 11:04am
AkramMSiddique @AkramMSiddique
$GERN - Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis
April 13th 2021, 11:04am
stock_titan @stock_titan
$GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis… https://t.co/EDG9B4lEk5
April 13th 2021, 11:04am
Gambiste1 @Gambiste1
RT @_sdrawkcabeman_: The Dec 10th ASH 2018 CC Part 2 of 8 $GERN https://t.co/e8NHrjpHUr
April 10th 2021, 6:04pm
Gambiste1 @Gambiste1
RT @_sdrawkcabeman_: The Dec 10th ASH 2018 CC Part 1 of 8 $GERN https://t.co/jlIrSVwoDq
April 10th 2021, 6:04pm
Gambiste1 @Gambiste1
RT @_sdrawkcabeman_: A note on Imerge, Part1/3. $GERN 7/13(54%) TI in original. PREMATURE expansion data was 7/25(28%); but mean burden=6…
April 10th 2021, 6:04pm
Gambiste1 @Gambiste1
RT @_sdrawkcabeman_: A note on Imerge, Part2/3. $GERN HI-E =71% w/68% reduction! +today's data says mTI not yet reached, data STILL DEVELO…
April 10th 2021, 6:04pm
Gambiste1 @Gambiste1
RT @_sdrawkcabeman_: A note on Imerge, Part3/3. $GERN Incredible DEPTH of response gives me sufficient reason to blve more pts w/mean 2 ex…
April 10th 2021, 6:04pm
OmarPridelands @OmarPridelands
RT @_sdrawkcabeman_: The Dec 10th ASH 2018 CC Part 3 of 8 $GERN https://t.co/HEYi7Uc1fT
April 10th 2021, 6:04pm
OmarPridelands @OmarPridelands
RT @_sdrawkcabeman_: The Dec 10th ASH 2018 CC Part 4 of 8 $GERN https://t.co/QdeTG5U2Ia
April 10th 2021, 6:04pm
OmarPridelands @OmarPridelands
RT @_sdrawkcabeman_: The Dec 10th ASH 2018 CC Part 5 of 8 $GERN https://t.co/4kAkEbZE2Q
April 10th 2021, 6:04pm
OmarPridelands @OmarPridelands
RT @_sdrawkcabeman_: The Dec 10th ASH 2018 CC Part 6 of 8 $GERN https://t.co/yzy7QFx9DU
April 10th 2021, 6:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.